Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Biocapital II Lp Hbm currently holds 1,426,061 shares of Allena Pharmaceuticals, Inc. (ALNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biocapital II Lp Hbm has been a net buyer of ALNA stock. They have purchased $1000.0K and sold $0 worth of shares.
Biocapital II Lp Hbm's most recent insider trade was on Nov 6, 2017, when they sold 1,426,061 shares at $0.00 per share.
Biocapital II Lp Hbm serves as Executive at Allena Pharmaceuticals, Inc. (ALNA). They have executed 3 insider transactions totaling $1000.0K over their tenure at the company.
Biocapital II Lp Hbm holds the position of Executive at Allena Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Biocapital II Lp Hbm has shown a buying trading pattern, with $1000.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Biocapital II Lp Hbm was on Nov 6, 2017, when they purchased $1000.0K worth of ALNA shares. This transaction involved 71,428 shares at $14.00 per share.
Biocapital II Lp Hbm currently owns 1,426,061 shares of Allena Pharmaceuticals, Inc. (ALNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Biocapital II Lp Hbm's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Biocapital II Lp Hbm has 3 Form 4 filings on record as an insider at Allena Pharmaceuticals, Inc..
Set alerts for Biocapital II Lp Hbm and 40,000+ other insiders.